Description
XYREM PRESCRIPTION DRUG
First action · last action
2014-03-20 · 2014-10-09
Transactions
3
First transaction's obligation
$68,468
Base + all options value (sum of deltas)
$47,876
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0419
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-03-20+$68,468= $68,468
- Mod P000012014-04-24-$3,604= $64,865
- Mod P000022014-10-09-$16,988= $47,876
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-03-20 | +$68,468 | $68,468 | XYREM PRESCRIPTION DRUG |
| Mod P00001· FUNDING ONLY ACTION | 2014-04-24 | −$3,604 | $64,865 | XYREM PRESCRIPTION DRUG |
| Mod P00002· FUNDING ONLY ACTION | 2014-10-09 | −$16,988 | $47,876 | XYREM PRESCRIPTION DRUG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H9AXCNRA5NE6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0282 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $14,672 | FY2026 |
| 36C26026F0146 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $397,859 | FY2026 |
| 36C24526N0198 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $14,243 | FY2026 |
| 36C26026F0012 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $133,028 | FY2026 |
| 36C26026F0013 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $231,127 | FY2026 |
| 36C26026F0027 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25616P0619 | BIOCOMPATIBLES, INC. | 256-NETWORK CONTRACT OFFICE 16 | $147,500 | FY2016 |
| VA25616E3628 | MCKESSON CORPORATION | 256-NETWORK CONTRACT OFFICE 16 | $17,878,985 | FY2016 |
| VA25616F0536 | RETURNS 'R' US, LLC | 256-NETWORK CONTRACT OFFICE 16 | $0 | FY2016 |
| VA25616P0541 | MCKESSON PLASMA AND BIOLOGICS LLC | 256-NETWORK CONTRACT OFFICE 16 | $10,851 | FY2016 |
| VA25616P0522 | BIOCOMPATIBLES, INC. | 256-NETWORK CONTRACT OFFICE 16 | $32,000 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25614F1483_3600_VA797BP0419_3600 · retrieved 2026-09-26.